Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)
Clinical trial NCT02842320 · COMPLETED
Trial details
- NCT number
- NCT02842320
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-14
- Primary completion
- 2020-07-15
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.